CELL INTELLIGENCE · 肿瘤细胞治疗研究

衰老相关细胞与基因的整合分析鉴定 UGT1A7 为肺鳞状细胞癌的预后和治疗靶点

Integrative profiling of senescence-associated cells and genes identifies UGT1A7 as a prognostic and therapeutic target in Lung squamous cell carcinom

CAR-NK 细胞生物学与工程化用于实体瘤，重点关注肺癌

CAR-NK Cell Biology and Engineering for Solid Tumors, With a Focus on Lung Cancer.

播散性堪萨斯分枝杆菌感染揭示疑似结核与早期肺癌后的 GATA2 单倍剂量不足

Disseminated mycobacterium kansasii infection revealing GATA2 haploinsufficiency after presumed tuberculosis and early lung cancer.

胶质母细胞瘤免疫治疗临床试验研究进展

An update on the clinical trial research of immunotherapy for glioblastoma.

免疫衰老对非小细胞肺癌（NSCLC）治疗影响的机制与策略：综合分析与未来方向

Mechanisms and strategies of immunosenescence effects on non-small cell lung cancer (NSCLC) treatment: A comprehensive analysis and future directions.

NK 细胞输注克服老年小鼠对 PD-(L)1 治疗的耐药

NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice.

我们的研究发现，老年患者对免疫治疗的敏感性降低，老年小鼠中亦是如此。

多组学方法改善老年肺癌患者基于免疫检查点阻断和细胞因子诱导的杀伤细胞输注的个体化治疗：一例病例报告及文献综述

Multi‑omics approach to improve patient‑tailored therapy using immune checkpoint blockade and cytokine‑induced killer cell infusion in an elderly pati

获得性克唑替尼耐药肺腺癌及后续原发性胆囊癌：一例病例报告

Acquired crizotinib-resistant pulmonary adenocarcinoma and subsequent primary gallbladder cancer: A case report.

在诊断方面，精准的生物信息学分析与重复活检具有同等价值。

免疫治疗（不含检查点抑制剂）用于接受根治性手术或放疗的 I 至 III 期非小细胞肺癌

Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative inten